SIGA Tech (SIGA) Files Notice of Appeal in Delaware to Overturn PharmAthene Order
Tweet
Share
E-mailGet Alerts SIGA Hot Sheet
Join SI Premium – FREE
SIGA Technologies, Inc. (Nasdaq: SIGA), has filed a Notice of Appeal seeking to overturn the Delaware Chancery Court's May 31, 2012 final order and judgment in the litigation that PharmAthene, Inc. commenced in December 2006.
Dr. Eric A. Rose, SIGA's Chief Executive Officer, commented, "We look forward to the opportunity to show why the Chancery Court's rulings were made in error."
While SIGA believes its appellate arguments are meritorious, no assurance can be given that the appeal will be successful.
Dr. Eric A. Rose, SIGA's Chief Executive Officer, commented, "We look forward to the opportunity to show why the Chancery Court's rulings were made in error."
While SIGA believes its appellate arguments are meritorious, no assurance can be given that the appeal will be successful.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Boeing names Ryan Shedd as new SVP and controller
- Lazard Global Total Return fund declares $0.1534 monthly distribution
- Elroy Air wins $46M U.S. Army contract for cargo drone system
Create E-mail Alert Related Categories
Corporate News, LitigationSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
